C. Noblet

1.0k total citations
17 papers, 633 citations indexed

About

C. Noblet is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, C. Noblet has authored 17 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in C. Noblet's work include Lipoproteins and Cardiovascular Health (3 papers), Poisoning and overdose treatments (2 papers) and Pharmacology and Obesity Treatment (2 papers). C. Noblet is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Poisoning and overdose treatments (2 papers) and Pharmacology and Obesity Treatment (2 papers). C. Noblet collaborates with scholars based in France, United Kingdom and United States. C. Noblet's co-authors include Nicholas Moore, Christian Thuillez, I. Marie, Nathalie Massy, Michel Ollagnier, C. Kreft-Jaïs, Nicholas M. Moore, Bernard Bégaud, Françoise Haramburu and Michel Andréjak and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Clinical Pharmacology and Clinical Endocrinology.

In The Last Decade

C. Noblet

15 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Noblet France 8 280 156 149 148 129 17 633
Katrin Farker Germany 10 97 0.3× 134 0.9× 96 0.6× 104 0.7× 77 0.6× 31 483
L. V. Wilton United Kingdom 15 129 0.5× 40 0.3× 226 1.5× 161 1.1× 90 0.7× 22 816
Yannick Arimone France 11 233 0.8× 79 0.5× 93 0.6× 110 0.7× 70 0.5× 11 572
Pipasha Biswas United Kingdom 10 137 0.5× 50 0.3× 89 0.6× 98 0.7× 33 0.3× 15 528
TJ White United States 6 56 0.2× 113 0.7× 83 0.6× 47 0.3× 26 0.2× 10 434
Y Zopf Germany 15 143 0.5× 102 0.7× 120 0.8× 81 0.5× 185 1.4× 22 833
Miguel Gil Spain 13 49 0.2× 47 0.3× 61 0.4× 119 0.8× 130 1.0× 37 643
Yun Mi Yu South Korea 13 78 0.3× 45 0.3× 33 0.2× 95 0.6× 68 0.5× 50 563
Sabine Krebs Germany 10 208 0.7× 188 1.2× 206 1.4× 82 0.6× 46 0.4× 22 472
Eline M. Rodenburg Netherlands 13 70 0.3× 86 0.6× 69 0.5× 50 0.3× 65 0.5× 15 687

Countries citing papers authored by C. Noblet

Since Specialization
Citations

This map shows the geographic impact of C. Noblet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Noblet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Noblet more than expected).

Fields of papers citing papers by C. Noblet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Noblet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Noblet. The network helps show where C. Noblet may publish in the future.

Co-authorship network of co-authors of C. Noblet

This figure shows the co-authorship network connecting the top 25 collaborators of C. Noblet. A scholar is included among the top collaborators of C. Noblet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Noblet. C. Noblet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Marie, I. & C. Noblet. (2010). Tendinopathies induites par les statines. 16(3). 238–243. 1 indexed citations
2.
Marie, I., et al.. (2008). Tendinous disorders attributed to statins: A study on ninety‐six spontaneous reports in the period 1990–2005 and review of the literature. Arthritis Care & Research. 59(3). 367–372. 127 indexed citations
3.
Marie, I., et al.. (2008). Complications tendineuses des statines : à propos de 96 observations. Journal des Maladies Vasculaires. 33. S34–S35. 1 indexed citations
4.
Riachi, Ghassan, C. Noblet, Odile Goria, et al.. (2004). Acute hepatitis due to buprenorphine administration. European Journal of Gastroenterology & Hepatology. 16(10). 1033–1037. 34 indexed citations
5.
Cailleux, N., et al.. (2000). [Spontaneous hematoma: thoughts about selective serotonin uptake inhibitors].. PubMed. 25(1). 63–4. 2 indexed citations
6.
Moore, Nicholas, et al.. (1998). Frequency and cost of serious adverse drug reactions in a department of general medicine. British Journal of Clinical Pharmacology. 45(3). 301–308. 247 indexed citations
7.
Moore, Nicholas M., et al.. (1997). [Focus on the safety of ibuprofen at the analgesic-antipyretic dose].. PubMed. 51(4). 458–63. 15 indexed citations
8.
Moore, Nicholas M., C. Kreft-Jaïs, Françoise Haramburu, et al.. (1997). Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non‐case study in the French pharmacovigilance system database. British Journal of Clinical Pharmacology. 44(5). 513–518. 108 indexed citations
9.
Moore, Nicholas, et al.. (1997). Renal failure with fluoroquinolones.. PubMed. 51(4). 421–3. 1 indexed citations
10.
Joly, P., et al.. (1996). Toxic epidermal necrolysis after mifepristone/gemeprost-induced abortion. Journal of the American Academy of Dermatology. 35(1). 112–112. 6 indexed citations
11.
Moore, Nicholas, C. Noblet, C. Kreft-Jaïs, et al.. (1996). [French pharmacovigilance database system: examples of utilisation].. PubMed. 50(6). 557–62. 52 indexed citations
12.
Lefèbvre, Hervé, C. Noblet, Nicholas Moore, & L M Wolf. (1995). Pseudo‐phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline. Clinical Endocrinology. 42(1). 95–98. 24 indexed citations
13.
Houdent, C, C. Noblet, H. Lévesque, et al.. (1991). Hypoglycémie induite par la cibenzoline chez le sujet âgé. La Revue de Médecine Interne. 12(2). 143–145. 8 indexed citations
14.
Lévesque, H., N. Cailleux, C. Noblet, et al.. (1991). [Hypoaldosteronism induced by low molecular weight heparins].. PubMed. 20(1). 35–35. 1 indexed citations
15.
Noblet, C., et al.. (1991). Severe polyarthropathy in an adolescent treated with pefloxacin.. PubMed. 18(12). 1941–2. 5 indexed citations
16.
Lévesque, H., et al.. (1991). [Megaloblastic anemia secondary to ingestion of metformin].. PubMed. 46(1). 89–90. 1 indexed citations
17.
Rostin, M, Gautier Paux, C. Noblet, et al.. (1989). [2 epidemics of acute kidney failure caused by piromidic acid].. PubMed. 43(5). 426–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrin Farker Breakdown of academic impact, for papers by L. V. Wilton Breakdown of academic impact, for papers by Yannick Arimone Breakdown of academic impact, for papers by Pipasha Biswas Breakdown of academic impact, for papers by TJ White Breakdown of academic impact, for papers by Y Zopf Breakdown of academic impact, for papers by Miguel Gil Breakdown of academic impact, for papers by Yun Mi Yu Breakdown of academic impact, for papers by Sabine Krebs Breakdown of academic impact, for papers by Eline M. Rodenburg
Rankless by CCL
2026